Australia's largest stock trading and investment forum Australia's #1 stock forum

CHM

0.00%

1.4¢ chimeric therapeutics limited

I am an idiot. Wrote over 8 million shares traded when meant 80...

First 18 Last

Share
Profile

Follow
dalts66

4,364 Posts.

2034

02/11/23

16:16

Post #: 70694173
Share

Originally posted by dalts66: ↑

Steini,
You have become an emotional and fearful investor. Your theories re PH really need to stay on the IMU threads, where you can find some like minded folk.

The over 8 million shares traded on the 31st was not due to someone getting approval confused with IND. Nor has the higher trading volume for the last weeks. This is purely on pipeline development vs market cap. Lots of chatter on this in some other sites I visit. Some overseas. The data delivered about the GBM trial is compelling. The main risk now is Finance. And this is why the SPP is so important. Without the cash, something has to give. Look at the available pivot points by the end of next year if the money comes in. Freaking amazing. If we dont get all the funds the cd17 will have to slide. And this was announced after the last CR. The BOD are deferring payments and concentrating funds into getting this pipeline into arms. Good on them. This is what a drug discovery biotech needs.

Love him or hate him PH has found some awesome drugs to develop, and has ensured he has the right people available to get it done. He has put his money where his mouth is, so to speak.

An SPP at a higher price would not have worked in the environment.

Expand

I am an idiot. Wrote over 8 million shares traded when meant 80 million. Doh!

CHM Price at posting: 2.9¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BUX

Buxton projects new graphite province discovery at WA Narryer play

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 39 more messages in this thread...

First 18 Last

Add CHM (ASX) to my watchlist

(20min delay)
Last 1.4¢		Change 0.000(0.00%)		Mkt cap ! $12.67M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

I am an idiot. Wrote over 8 million shares traded when meant 80...

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Buxton projects new graphite province discovery at WA Narryer play

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Featured News

I am an idiot. Wrote over 8 million shares traded when meant 80...

Top Stories

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Buxton projects new graphite province discovery at WA Narryer play

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Featured News